Novel approaches to surfactant administration
- PMID: 23243504
- PMCID: PMC3518953
- DOI: 10.1155/2012/278483
Novel approaches to surfactant administration
Abstract
Surfactant replacement therapy has been the mainstay of treatment for preterm infants with respiratory distress syndrome for more than twenty years. For the most part, surfactant is administered intratracheally, followed by mechanical ventilation. In recent years, the growing interest in noninvasive ventilation has led to novel approaches of administration. This paper will review these techniques and the associated clinical evidence.
References
-
- Stevens TP, Harrington EW, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database of Systematic Reviews. 2007;(4)CD003063 - PMC - PubMed
-
- O’Donnell CPF, Kamlin COF, Davis PG, Morley CJ. Endotracheal intubation attempts during neonatal resuscitation: success rates, duration, and adverse effects. Pediatrics. 2006;117(1):e16–e21. - PubMed
-
- Gupta S, Sinha SK, Donn SM. Myth: mechanical ventilation is a therapeutic relic. Seminars in Fetal and Neonatal Medicine. 2011;16(5):275–278. - PubMed
-
- Verder H, Robertson B, Greisen G, et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. New England Journal of Medicine. 1994;331(16):1051–1055. - PubMed
-
- Avery ME, Tooley WH, Keller JB. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics. 1987;79(1):26–30. - PubMed
LinkOut - more resources
Full Text Sources
